NAHSV Healthlinko Private Limited today announced the completion of its first year of operations, highlighting a milestone shaped by strong fundamentals, profitable growth and growing international reach through its flagship healthcare platform, MediFyr.
Founded in April 2025, the company was established to build technology-led solutions that improve healthcare access and simplify the patient journey. One year into operations, NAHSV Healthlinko said it has translated that vision into measurable traction through patient growth, revenue performance and expanding strategic partnerships.
Leading this progress is MediFyr, which has emerged as the company’s flagship brand and currently supports more than 2,000 patients every month across medical access and patient support services. The company said this growth contributed to ₹65 lakh in revenue in the last quarter of the previous financial year, reflecting strong early demand and validating the strength of its operating model.
NAHSV Healthlinko noted that these milestones have been achieved without external investment, with the company operating as a bootstrapped and profitable business throughout its first year. Management said the company’s approach has prioritized sustainable execution, disciplined growth and long-term value creation rather than growth driven solely by capital.
“The first year has been about building strong fundamentals,” the company said in a statement. “Those fundamentals — profitability, patient trust and strategic partnerships — now create the base for larger scale.”
In parallel with MediFyr’s growth, the company has continued expanding its broader digital health portfolio, including Zerunio, WhatPregnant, HealthSetu and Unikorn, supporting a multi-brand strategy designed to address broader opportunities across healthcare and wellness.
Looking ahead, global expansion is expected to play a significant role in the company’s next phase. Through MediFyr, NAHSV Healthlinko has already established partnerships and signed hospitals across Turkey, Egypt, Israel, Thailand, UAE and China, creating an early international network to support cross-border healthcare access and medical facilitation.
According to the company, these relationships provide a foundation for deeper global engagement and position MediFyr for continued expansion in international markets.
As the company enters year two, priorities include increasing patient reach, strengthening provider networks, expanding technology capabilities and accelerating international growth.
With strong fundamentals established, profitable operations in place and international partnerships underway, the company said it believes it is well positioned to enter a broader phase of growth.
